Models of Integration of Specialized Palliative Care with Oncology.


Journal

Current treatment options in oncology
ISSN: 1534-6277
Titre abrégé: Curr Treat Options Oncol
Pays: United States
ID NLM: 100900946

Informations de publication

Date de publication:
08 04 2021
Historique:
accepted: 18 02 2021
entrez: 8 4 2021
pubmed: 9 4 2021
medline: 22 4 2021
Statut: epublish

Résumé

Evidence from randomized controlled trials and meta-analyses has shown that early integration of specialized palliative care improves symptoms and quality of life for patients with advanced cancer. There are various models of early integration, which may be classified based on setting of care and method of palliative care referral. Most successful randomized controlled trials of early palliative care have used a model of specialized teams providing in-person palliative care in free-standing or embedded outpatient clinics. During the COVID-19 pandemic, telehealth has become a prominent model for palliative care delivery. This model of care has been well received by patients and palliative care providers, although evidence to date is limited. Despite evidence from trials that routine early integration of palliative care into oncology care improves patient outcomes, referral to palliative care still occurs mostly according to the judgment of individual oncologists. This hinders equitable access to palliative care and to its known benefits for patients and their caregivers. Automated referral based on triggering criteria is being actively explored as an alternative. In particular, routine technology-assisted symptom screening, combined with targeted needs-based automatic referral to outpatient palliative care, may improve integration and ultimately increase quality of life.

Identifiants

pubmed: 33830352
doi: 10.1007/s11864-021-00836-1
pii: 10.1007/s11864-021-00836-1
pmc: PMC8027976
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

44

Références

J Med Internet Res. 2017 Jan 09;19(1):e11
pubmed: 28069561
BMJ Support Palliat Care. 2019 May 8;:
pubmed: 31068333
J Clin Oncol. 2018 Apr 10;36(11):1096-1102
pubmed: 29474102
BMC Cancer. 2019 Jul 1;19(1):646
pubmed: 31262285
BMC Palliat Care. 2020 Apr 22;19(1):55
pubmed: 32321487
J Pain Symptom Manage. 2018 Jun;55(6):1500-1508
pubmed: 29496534
Support Care Cancer. 2013 Jun;21(6):1751-9
pubmed: 23338230
CMAJ. 2016 Jul 12;188(10):E217-E227
pubmed: 27091801
J Oncol Pract. 2014 Mar;10(2):e37-44
pubmed: 24301842
Pain. 2018 Sep;159 Suppl 1:S74-S80
pubmed: 30113950
BMJ Support Palliat Care. 2017 Mar;7(1):23-31
pubmed: 25012126
J Oncol Pract. 2017 Sep;13(9):e729-e737
pubmed: 28562197
J Pain Symptom Manage. 2016 Apr;51(4):662-672.e8
pubmed: 26743641
Support Care Cancer. 2006 Oct;14(10):982-7
pubmed: 16802127
Support Care Cancer. 2019 Jul;27(7):2425-2434
pubmed: 30357555
Ann Oncol. 2017 Jan 1;28(1):163-168
pubmed: 27687308
Palliat Med. 2015 Feb;29(2):101-11
pubmed: 25395577
J Pain Symptom Manage. 2020 Jul;60(1):e31-e40
pubmed: 32278097
J Clin Oncol. 2015 May 1;33(13):1438-45
pubmed: 25800768
Support Care Cancer. 2015 Apr;23(4):1073-80
pubmed: 25281230
J Clin Oncol. 2015 May 1;33(13):1446-52
pubmed: 25800762
CA Cancer J Clin. 2018 Sep;68(5):356-376
pubmed: 30277572
JAMA. 2016 Nov 22;316(20):2104-2114
pubmed: 27893131
Support Care Cancer. 2021 Jan;29(1):485-490
pubmed: 32405963
Palliat Med. 2020 Feb;34(2):209-218
pubmed: 31659940
Eur J Cancer. 2016 Sep;65:61-8
pubmed: 27472648
J Med Internet Res. 2015 Mar 13;17(3):e65
pubmed: 25793945
Oncologist. 2021 Apr;26(4):332-340
pubmed: 33284483
Lancet Oncol. 2016 Dec;17(12):e552-e559
pubmed: 27924753
Health Psychol. 2017 Jun;36(6):538-548
pubmed: 28277698
Ann Palliat Med. 2019 Sep;8(4):381-389
pubmed: 30943735
BMC Palliat Care. 2020 May 19;19(1):71
pubmed: 32429888
Support Care Cancer. 2018 Jan;26(1):61-79
pubmed: 28932908
Lancet Oncol. 2018 Nov;19(11):e588-e653
pubmed: 30344075
Cancer. 2018 Sep 15;124(18):3656-3667
pubmed: 30216477
Lancet Oncol. 2018 Mar;19(3):394-404
pubmed: 29402701
J Clin Oncol. 2016 Feb 20;34(6):557-65
pubmed: 26644527
Support Care Cancer. 2018 Feb;26(2):337-351
pubmed: 28921391
Am Soc Clin Oncol Educ Book. 2019 Jan;39:332-340
pubmed: 31099640
J Clin Oncol. 2017 Mar 10;35(8):834-841
pubmed: 28029308
Palliat Med. 2020 Jan;34(1):114-125
pubmed: 31849272
J Oncol Pract. 2017 Sep;13(9):e792-e799
pubmed: 28813191
J Palliat Med. 2018 Aug 1;:
pubmed: 30067150
J Pain Symptom Manage. 2018 Jun;55(6):1519-1530
pubmed: 29474939
BMC Med. 2017 Jun 19;15(1):119
pubmed: 28625164
J Clin Oncol. 2017 Jan;35(1):96-112
pubmed: 28034065
Cancer. 2014 Jun 1;120(11):1743-9
pubmed: 24967463
Indian J Palliat Care. 2017 Jul-Sep;23(3):261-267
pubmed: 28827928
Cochrane Database Syst Rev. 2020 Jun 2;6:CD007568
pubmed: 32483832
Ann Oncol. 2015 Sep;26(9):1953-1959
pubmed: 26088196
Support Care Cancer. 2016 Sep;24(9):3873-81
pubmed: 27086311
BMJ Support Palliat Care. 2019 Aug 12;:
pubmed: 31406013
N Engl J Med. 2010 Aug 19;363(8):733-42
pubmed: 20818875
Lancet. 2014 May 17;383(9930):1721-30
pubmed: 24559581
Support Care Cancer. 2010 Jan;18(1):43-9
pubmed: 19381693
Ann Behav Med. 2019 Jun 4;53(7):674-685
pubmed: 30265282
Palliat Med. 2019 Feb;33(2):123-134
pubmed: 30488781
Support Care Cancer. 2011 Jul;19(7):1037-43
pubmed: 21432009
Lancet. 2014 May 17;383(9930):1699-700
pubmed: 24559580
J Clin Oncol. 2012 Dec 10;30(35):4380-6
pubmed: 23109708
J Palliat Care. 2017 Jan;32(1):3-10
pubmed: 28662623
JAMA Intern Med. 2013 Feb 25;173(4):283-90
pubmed: 23358690
J Clin Oncol. 2016 Jan 1;34(1):62-8
pubmed: 26578612
BMC Med. 2020 Nov 26;18(1):368
pubmed: 33239021
Eur J Cancer Care (Engl). 2018 Jan;27(1):
pubmed: 28134475
Cancer. 2020 Jan 1;126(9):2013-2023
pubmed: 32049358
Cochrane Database Syst Rev. 2017 Jun 12;6:CD011129
pubmed: 28603881
Palliat Med. 2017 Oct;31(9):814-824
pubmed: 28494643
PLoS One. 2015 Apr 22;10(4):e0124387
pubmed: 25902263
N Engl J Med. 2013 Mar 28;368(13):1173-5
pubmed: 23465068
Support Care Cancer. 2018 Jan;26(1):175-180
pubmed: 28726065
J Natl Compr Canc Netw. 2021 Sep 7;:1-10
pubmed: 34492632
J Palliat Med. 2015 Nov;18(11):962-9
pubmed: 26305992
Oncologist. 2017 Dec;22(12):1528-1534
pubmed: 28894017
Eur J Cancer Care (Engl). 2019 Jul;28(4):e13024
pubmed: 30784150
Oncologist. 2016 Nov;21(11):1387-1395
pubmed: 27449522
J Palliat Med. 2018 Sep;21(9):1322-1328
pubmed: 29630413
JAMA Oncol. 2017 Nov 1;3(11):1459-1460
pubmed: 28520825
Palliat Med. 2017 Jan;31(1):72-81
pubmed: 27495814
J Oncol Pract. 2016 May;12(5):e513-26
pubmed: 27048610
Am J Med. 2017 Feb;130(2):113-114
pubmed: 27687068
Ann Oncol. 2018 Jan 1;29(1):36-43
pubmed: 29253069
Palliat Med. 2017 Apr;31(4):296-305
pubmed: 28156188
J Palliat Med. 2019 Sep;22(S1):7-19
pubmed: 31486721
Nat Rev Clin Oncol. 2020 Jun;17(6):339-340
pubmed: 32355317
BMJ. 2017 Jul 4;357:j2925
pubmed: 28676557
Nat Rev Clin Oncol. 2016 Mar;13(3):159-71
pubmed: 26598947
JAMA. 2009 Aug 19;302(7):741-9
pubmed: 19690306
Oncologist. 2016 Jul;21(7):895-901
pubmed: 27185614

Auteurs

Jean Mathews (J)

Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, 610 University Ave., 16-712, Toronto, Ontario, M5G 2M9, Canada.
Divisions of Palliative Medicine and Medical Oncology, University of Toronto, Toronto, Canada.

Breffni Hannon (B)

Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, 610 University Ave., 16-712, Toronto, Ontario, M5G 2M9, Canada.
Divisions of Palliative Medicine and Medical Oncology, University of Toronto, Toronto, Canada.
Department of Medicine, University of Toronto, Toronto, Canada.

Camilla Zimmermann (C)

Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, 610 University Ave., 16-712, Toronto, Ontario, M5G 2M9, Canada. camilla.zimmermann@uhn.on.ca.
Divisions of Palliative Medicine and Medical Oncology, University of Toronto, Toronto, Canada. camilla.zimmermann@uhn.on.ca.
Department of Medicine, University of Toronto, Toronto, Canada. camilla.zimmermann@uhn.on.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH